Follow the Pundits
Tag: stock market
🏒 Glenview Capital & Larry Robbins: The $5.5B “Hockey Jersey” Hedge Fund Slashing Wall Street 🏥⚡
Larry Robbins has built Glenview Capital around fundamental research, concentrated conviction and an unusual willingness to act like an owner. We examine its ~$5.5B Q2 2026 portfolio, CVS activism, healthcare bets, extraordinary early track record—and why hockey may explain more about Robbins than you'd expect. 🏒
🚀 The House of Elon & Patience: Inside Ron Baron’s Compounding Engine 🪐🎢
Ron Baron built an investing career around a deceptively difficult idea: find exceptional businesses, back exceptional leaders and wait. We examine Baron Partners Fund, its huge SpaceX and Tesla exposure, long-term compounding record—and the concentration risk that comes with conviction.
🏛️ Mario Gabelli & GAMCO Investors: Inside the 14.1% Compounding Machine, PMV Investing, and the $11.2 Billion Value Vault
Mario Gabelli transformed value investing by asking a different question: What would an informed buyer pay for the entire business? We explore the PMV framework, the Catalyst™ strategy, GAMCO's $36.6 billion asset base, 1,019-stock portfolio, and nearly five decades of compounding.
🤫 ValueAct Capital Portfolio 2026: The Quiet Activist Fund Rewiring Corporate America
ValueAct Capital doesn’t fight corporate wars in public — it quietly rewires companies from inside the boardroom. Discover the fund’s $5.9B 2026 portfolio, biggest stock bets, stealth activist strategy, and why Wall Street fears the calmest investors the most.
🏦 Alkami Technology (ALKT): The “Picks and Shovels” of Digital Banking
Alkami Technology (ALKT) isn’t a bank — it’s the digital engine powering modern banking for millions of users. After a brutal fintech reset, General Atlantic just bought another $34M worth of shares. Coincidence… or conviction?
Baillie Gifford Review 2026: The Long-Term Kings of Disruptive Growth 🏴☠️
Baillie Gifford invests like a time traveler—betting on companies that could dominate the next decade. But with great upside comes serious volatility. Here’s the full 2026 breakdown.
🏰 The $387 Billion Macro-Machine: Inside Fisher Investments (2026 Edition)
Fisher Investments doesn’t start with stocks—it starts with the world. With $387B under management, this macro-first powerhouse takes a very different approach to investing. Here’s what’s really going on under the hood.
Sweetgreen (SG): 90% Down—Turnaround or Trap? 🥗📉
Sweetgreen looks fresh on the menu—but the stock tells a different story. With high short interest, insider buying, and weak fundamentals, SG is a high-risk contrarian bet investors should approach carefully.
NVIDIA (NVDA) Stock Analysis 2026: Is the AI King Still Investable? 🚀
NVIDIA isn’t just riding the AI wave—it is the wave. But at $172, is NVDA still a smart play, or are investors dancing a little too close to perfection?
Daniel Loeb Still Thinks PG&E Stands for Purchase, Grab & Enjoy
PG&E has gone from fiery headlines to financial footing—and Daniel Loeb’s Third Point is all-in. With 14% of his portfolio riding on PCG, a growing customer base, and wildfire risks contained (for now), is this survivor stock worth a second look?
2 comments
|